Oxytrol is indicated for the relief of symptoms of urinary incontinence, urgency and frequency in the unstable bladder, whether due to neurogenic bladder disorders (detrusor hyperreflexia) in conditions such as multiple sclerosis and spina bifida, or to idiopathic detrusor instability (motor urge incontinence).
Children over 5 years of age: In addition to neurogenic bladder disorders, Oxytrol may also be used in nocturnal enuresis in conjunction with non-drug therapy where this alone, or in conjunction with other drug treatment, has failed.
How to use
Adults: The usual dose is 5mg two or three times a day. This may be increased to a maximum of 5 mg four times a day to obtain a clinical response provided that the side effects are tolerated.
Elderly (including frail elderly): The elimination half-life is increased in the elderly. Therefore, a dose of 2.5mg twice a day, particularly if the patient is frail, is likely to be adequate. This dose may be titrated upwards to 5mg two times a day to obtain a clinical response provided the side effects are well tolerated.
Children (under 5 years of age): Not recommended.
Children (over 5 years of age): Neurogenic bladder instability: the usual dose is 2.5mg twice a day. This dose may be titrated upwards to 5mg two or three times a day to obtain a clinical response provided the side effects are well tolerated.
Nocturnal enuresis: the usual dose is 2.5mg twice a day. This dose may be titrated upwards to 5mg two or three times a day to obtain a clinical response provided the side effects are tolerated. The last dose should be given before bedtime.
Drug Class and Mechanism
Oxytrol is an anticholinergic. It works by relaxing muscles in the bladder.
Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at the next regularly scheduled time. Do not take extra medicine to make up the missed dose.
Store this medicine at room temperature in a tightly-closed container, away from heat and light.
- Increased sensitivity towards oxybutinine or any of its components.
- Myasthenia gravis.
- Glaucoma or eye front camera shallowness .
- Gastrointestinal constipation including intestinal obstruction, intestinal atony.
- Patients with toxic megacolon, heavy ulcerous colitis.
- Patients with urinary tract with urine outflow obstruction.